NATR — NATURES SUNSHINE PRODUCTS INC
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 275053 ·
Last close
$10.33
Market Cap
$179.01M
52W High
$28.14
52W Low
$9.38
ADV30
180,880
Next earnings
2026-11-04
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 116,603,000 | 84,962,000 | 5,282,000 | 1,890,000 | 268,232,000 | 89,377,000 | 96,550,000 |
| Jun 2026 | 116,985,000 | 86,174,000 | 5,481,000 | 3,538,000 | 259,823,000 | 82,503,000 | 90,507,000 |
| Mar 2026 | 122,892,000 | 89,977,000 | 9,545,000 | 5,118,000 | 261,458,000 | 87,578,000 | 94,542,000 |
| Dec 2025 | 123,807,000 | 89,779,000 | 5,322,000 | 4,107,000 | 261,146,000 | 93,891,000 | 99,593,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$19,637,000
Investing CF
$-9,130,000
Financing CF
$-17,123,000
CapEx
$-9,130,000
Dividends Paid
—
Buybacks
$-8,029,000
EPS Diluted TTM
$0.82
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$87,474,000
Inventory
$71,289,000
Receivables
$18,325,000
ST Investments
—
EBIT TTM
$24,521,000
Pretax Income TTM
$24,376,000
Interest Exp TTM
$145,000
Analysts
2
Yahoo Snapshot (yfinance, live)
Total Revenue
$480,287,008
EBITDA
$38,671,000
Free Cash Flow
$8,374,125
Enterprise Value
$120,014,792
Total Cash
$89,377,000
Total Debt
$21,028,000
Shares Out
17,328,776
Trailing EPS
$0.82
Book Value
$9.88
ROE
8.9%
ROA
6.0%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 480,144,000 | 24,743,000 | 19,521,000 | 261,146,000 | 99,593,000 | 161,553,000 | 35,321,000 |
| Dec 2024 | 454,364,000 | 20,095,000 | 7,696,000 | 240,855,000 | 79,864,000 | 155,313,000 | 25,298,000 |
| Dec 2023 | 445,320,000 | 18,749,000 | 15,076,000 | 249,773,000 | 90,233,000 | 154,058,000 | 41,226,000 |
| Dec 2022 | 421,910,000 | 16,258,000 | -390,000 | 229,778,000 | 82,731,000 | 142,905,000 | 710,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
$259,823,000
Forward EPS
$1.07
Max Pain — expiry 2027-02-19 (volume-derived — Yahoo OI feed degraded)
max pain strike: $15.00 · spot: $10.32 · call volume: 3 · put volume: 201Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| WHWK | Whitehawk Therapeutics, Inc. | $181.75M | $3.08 | — |
| SLGL | Sol-Gel Technologies Ltd. | $172.97M | $52.83 | — |
| PYXS | Pyxis Oncology, Inc. | $172.24M | $1.44 | — |
| RNAC | Cartesian Therapeutics, Inc. | $186.68M | $6.12 | — |
| IFRX | InflaRx N.V. | $169.47M | $1.15 | — |
News headlines (Yahoo Finance, 1h cache)
Nature’s Sunshine Announces Partnership with Health and Fitness Expert Peter Nielsen
2026-11-16 13:00 · Yahoo
Natures Sunshine Products Inc (NATR) Q3 2026 Earnings Call Highlights: Sales Slip 9% as China ...
2026-11-06 01:07 · Yahoo
Nature's Sunshine (NATR) Q3 2026 Earnings Call Transcript
2026-11-05 19:31 · Yahoo
Nature's Sunshine Products, Inc. Q3 2026 Earnings Call Summary
2026-11-05 13:30 · Yahoo
What Nature's Sunshine Products (NATR) Said on Its Q3 Earnings Call
2026-11-05 04:14 · Yahoo
Nature's Sunshine: Q3 Earnings Snapshot
2026-11-04 22:47 · Yahoo
Nature's Sunshine (NASDAQ:NATR) reports sales below analyst estimates in Q3 2026 earnings, stock drops 13.3%
2026-11-04 21:48 · Yahoo
Nature's Sunshine Reports Third Quarter 2026 Results
2026-11-04 21:05 · Yahoo
3 Reasons to avoid NATR and 1 stock to buy instead
2026-10-27 19:34 · Yahoo
Nature’s Sunshine Sets Third Quarter 2026 Conference Call for Wednesday, November 4, 2026, at 5:00 p.m. ET
2026-10-21 20:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.